Carlyle Group Inc. Spruce Biosciences, Inc. Transaction History
Carlyle Group Inc.
- $80.8 Million
- Q1 2025
A detailed history of Carlyle Group Inc. transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Carlyle Group Inc. holds 2,896,518 shares of SPRB stock, worth $376,547. This represents 1.04% of its overall portfolio holdings.
Number of Shares
2,896,518
Previous 2,896,518
-0.0%
Holding current value
$376,547
Previous $1.19 Million
29.32%
% of portfolio
1.04%
Previous 1.19%
Shares
1 transactions
Others Institutions Holding SPRB
# of Institutions
31Shares Held
15.1MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$381,71620.39% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$339,1860.05% of portfolio
-
Abingworth LLP London, X01.79MShares$233,0270.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$135,9570.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1MShares$130,0000.04% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $3.06M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...